Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Blockage of interleukin‐6 receptor ameliorates joint disease in murine collagen‐induced arthritis

Blockage of interleukin‐6 receptor ameliorates joint disease in murine collagen‐induced arthritis Objective To clarify the role of interleukin‐6 (IL‐6) in the pathogenesis of collagen‐induced arthritis (CIA). Methods CIA was induced by immunizing twice at a 3‐week interval with bovine type II collagen (CII) emulsified with complete adjuvant. Rat anti‐mouse IL‐6 receptor (anti‐IL‐6R) monoclonal antibody MR16‐1 or isotype‐matched control antibody KH‐5 was then injected once intraperitoneally. Symptoms of arthritis were evaluated with a visual scoring system, and serum anti‐CII antibody and IL‐6 levels were measured by enzyme‐linked immunosorbent assay. In addition, the CII responsiveness of splenic lymphocytes from mice with CIA was examined. Results In mice with CIA, excess production of IL‐6 in sera was observed within 24 hours after the first CII immunization, and then rapidly decreased. Serum IL‐6 increased again beginning 14 days after immunization, in conjunction with the onset of arthritis. When MR16‐1 was injected immediately after immunization with CII, it inhibited the development of arthritis in a dose‐dependent manner. Furthermore, MR16‐1‐treated mice exhibited lower serum levels of IgG anti‐CII antibody and reduced responsiveness of lymphocytes to CII. This suppressive effect was observed when MR16‐1 was injected on day 0 or 3, but not when injected on day 7 or 14. Conclusion IL‐6 produced after CII immunization appears to play an essential role in the immunity to CII, and anti‐IL‐6R antibody reduces the development of CIA by suppressing IL‐6 signal transduction. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatism Wiley

Blockage of interleukin‐6 receptor ameliorates joint disease in murine collagen‐induced arthritis

Download PDF
5 pages

Loading next page...
 
/lp/wiley/blockage-of-interleukin-6-receptor-ameliorates-joint-disease-in-murine-0shEE9w0TG

References (14)

Publisher
Wiley
Copyright
Copyright © 1998 by the American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P
pmid
9870868
Publisher site
See Article on Publisher Site

Abstract

Objective To clarify the role of interleukin‐6 (IL‐6) in the pathogenesis of collagen‐induced arthritis (CIA). Methods CIA was induced by immunizing twice at a 3‐week interval with bovine type II collagen (CII) emulsified with complete adjuvant. Rat anti‐mouse IL‐6 receptor (anti‐IL‐6R) monoclonal antibody MR16‐1 or isotype‐matched control antibody KH‐5 was then injected once intraperitoneally. Symptoms of arthritis were evaluated with a visual scoring system, and serum anti‐CII antibody and IL‐6 levels were measured by enzyme‐linked immunosorbent assay. In addition, the CII responsiveness of splenic lymphocytes from mice with CIA was examined. Results In mice with CIA, excess production of IL‐6 in sera was observed within 24 hours after the first CII immunization, and then rapidly decreased. Serum IL‐6 increased again beginning 14 days after immunization, in conjunction with the onset of arthritis. When MR16‐1 was injected immediately after immunization with CII, it inhibited the development of arthritis in a dose‐dependent manner. Furthermore, MR16‐1‐treated mice exhibited lower serum levels of IgG anti‐CII antibody and reduced responsiveness of lymphocytes to CII. This suppressive effect was observed when MR16‐1 was injected on day 0 or 3, but not when injected on day 7 or 14. Conclusion IL‐6 produced after CII immunization appears to play an essential role in the immunity to CII, and anti‐IL‐6R antibody reduces the development of CIA by suppressing IL‐6 signal transduction.

Journal

Arthritis & Rheumatism – Wiley

Published: Dec 1, 1998

There are no references for this article.